| Title : Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group - van Dyck_2000_Arch.Gen.Psychiatry_57_157 |
| Author(s) : van Dyck CH , Newhouse PA , Falk WE , Mattes JA |
| Ref : Arch Gen Psychiatry , 57 :157 , 2000 |
| Abstract : |
| PubMedSearch : van Dyck_2000_Arch.Gen.Psychiatry_57_157 |
| PubMedID: 10665618 |
| Title : Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group - van Dyck_2000_Arch.Gen.Psychiatry_57_157 |
| Author(s) : van Dyck CH , Newhouse PA , Falk WE , Mattes JA |
| Ref : Arch Gen Psychiatry , 57 :157 , 2000 |
| Abstract : |
| PubMedSearch : van Dyck_2000_Arch.Gen.Psychiatry_57_157 |
| PubMedID: 10665618 |
| Title : Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group - van Dyck_2000_Arch.Gen.Psychiatry_57_157 |
| Author(s) : van Dyck CH , Newhouse PA , Falk WE , Mattes JA |
| Ref : Arch Gen Psychiatry , 57 :157 , 2000 |
| Abstract : |
| PubMedSearch : van Dyck_2000_Arch.Gen.Psychiatry_57_157 |
| PubMedID: 10665618 |